CLINICAL_TRIALS
trial_result
· 2019-06-26
Clinical Trial Update: Fenofibrate Treatment in SCI [Phase 2, Phase 3]
Summary
Phase 2/3 trial investigating fenofibrate for spinal cord injury with dyslipidemia completed, with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Spinal Cord Injury, Dyslipidemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-06-26